SCHEMBL22232971

SCHEMBL22232971

COc1cc(-c2cc(=O)c3cccc(Cl)c3o2)cc(OC2CC(C)(C(=O)O)C2)c1OC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A1 P04798 2/20 0.49
▸ CYP1B1 Q16678 2/20 0.49
▸ CSNK2A2 P19784 8/20 0.47
▸ CSNK2B P67870 8/20 0.47
▸ CSNK2A1 P68400 8/20 0.47
▸ CYP1A2 P05177 1/20 0.44
▸ PABPC1 P11940 1/20 0.42
▸ TERT O14746 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.40
▸ CYP3A4 P08684 2/20 0.40
▸ MAPT P10636 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ PTGES O14684 1/20 0.39
▸ ALOX5 P09917 1/20 0.39
▸ ACHE P22303 1/20 0.39
▸ PLK1 P53350 1/20 0.39
▸ BACE1 P56817 1/20 0.39
▸ LCK P06239 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27116999 0.90 ABCB1 (0.48) CYP1A1CYP1B1CSNK2A2CSNK2BCSNK2A1
SCHEMBL22230957 0.88 HPGD (0.46) CYP1A1CYP1B1CSNK2A2CSNK2BCSNK2A1
SCHEMBL22230855 0.86 CYP1A1 (0.52) CYP1A1CYP1B1CSNK2A2CSNK2BCSNK2A1
SCHEMBL22230858 0.86 CYP1A1 (0.52) CYP1A1CYP1B1CSNK2A2CSNK2BCSNK2A1
SCHEMBL22231240 0.85 ALDH1A1 (0.43) CYP1A1CYP1B1CSNK2A2CSNK2BCSNK2A1
SCHEMBL22232972 0.84 CYP1A1 (0.51) CYP1A1CYP1B1CSNK2A2CSNK2BCSNK2A1
SCHEMBL22245255 0.84 CYP1A1 (0.51) CYP1A1CYP1B1CSNK2A2CSNK2BCSNK2A1
SCHEMBL22245265 0.84 CYP1A1 (0.51) CYP1A1CYP1B1CSNK2A2CSNK2BCSNK2A1
SCHEMBL22231935 0.83 CSNK2A2 (0.38) CYP1A1CYP1B1CSNK2A2CSNK2BCSNK2A1
SCHEMBL22231220 0.82 MAPT (0.38) CYP1A1CYP1B1CSNK2A2CSNK2BCSNK2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3911413-A1 SUBSTITUTED CHROMEN-4-ONE FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. Hoffmann-La Roche AG (CH) 2021-11-24 — — EP disclosed
WO-2020148354-A1 SUBSTITUTED CHROMEN-4-ONE FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. HOFFMANN-LA ROCHE AG (CH) 2020-07-23 — — WO disclosed
Send feedback